THE PAN-PPAR AGONIST LANIFIBRANOR IMPROVES PORTAL HYPERTENSION AND HEPATIC FIBROSIS IN EXPERIMENTAL ADVANCED CHRONIC LIVER DISEASE

Aristu, P; Boyer-Diaz, Z; Broqua, P; Junien, JL; Wettstein, G; Bosch, J; Gracia-Sancho, J

HEPATOLOGY, 2019; 70 (): 44A

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索